Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 31 results.
User Information
Export Records
  1. 1.   HIF1a Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid Synthesis
  2. Nishizawa, Hidekazu; Funasaki, Shintaro; Ma, Wenjuan; Kubota, Yoshiaki; Watanabe, Kazuhide; Arima, Yuichiro; Kuroda, Shoichiro; Ito, Takaaki; Furuya, Mitsuko; Motoshima, Takanobu; Nishiyama, Akira; Mehanna, Sally; Satou, Yorifumi; Hasumi, Hisashi; Jikuya, Ryosuke; Makiyama, Kazuhide; Tamura, Tomohiko; Oike, Yuichi; Tanaka, Yasuhito; Suda, Toshio; Schmidt,Laura; Linehan, W Marston; Baba, Masaya; Kamba, Tomomi
  3. Genes to Cells : devoted to molecular & cellular mechanisms. 2025, Jan; 30(1): e13195.
  1. 2.   Comprehensive proteogenomic characterization of rare kidney tumors
  2. Li, Ginny Xiaohe; Chen, Lijun; Hsiao, Yi; Mannan, Rahul; Zhang, Yuping; Luo, Jie; Petralia, Francesca; Cho, Hanbyul; Hosseini, Noshad; Leprevost, Felipe da Veiga; Calinawan, Anna; Li, Yize; Anand, Shankara; Dagar, Aniket; Geffen, Yifat; Kumar-Sinha, Chandan; Chugh, Seema; Le, Anne; Ponce, Sean; Guo, Shenghao; Zhang, Cissy; Schnaubelt, Michael; Al Deen, Nataly Naser; Chen, Feng; Caravan, Wagma; Houston, Andrew; Hopkins, Alex; Newton, Chelsea J; Wang, Xiaoming; Polasky, Daniel A; Haynes, Sarah; Yu, Fengchao; Jing, Xiaojun; Chen, Siqi; Robles, Ana I; Mesri, Mehdi; Thiagarajan,Mathangi; An, Eunkyung; Getz, Gad A; Linehan, W Marston; Hostetter, Galen; Jewell, Scott D; Chan, Daniel W; Wang, Pei; Omenn, Gilbert S; Mehra, Rohit; Ricketts, Christopher J; Ding, Li; Chinnaiyan, Arul M; Cieslik, Marcin P; Dhanasekaran, Saravana M; Zhang, Hui; Nesvizhskii, Alexey I
  3. Cell Reports. Medicine. 2024, May 21; 5(5): 101547.
  1. 3.   Development of a novel modified vaccine (TheraVacM) for curative treatment of mouse solid tumors
  2. Alam,Md Masud; Huang,Yue; Oppenheim, Joost J; Yang,De
  3. Cytokine. 2023, Jun 09; 169: 156270.
  1. 4.   Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma
  2. Jikuya, Ryosuke; Johnson, Todd A; Maejima, Kazuhiro; An, Jisong; Ju, Young-Seok; Lee, Hwajin; Ha, Kyungsik; Song, WooJeung; Kim, Youngwook; Okawa, Yuki; Sasagawa, Shota; Kanazashi, Yuki; Fujita, Masashi; Imoto, Seiya; Mitome, Taku; Ohtake, Shinji; Noguchi, Go; Kawaura, Sachi; Iribe, Yasuhiro; Aomori, Kota; Tatenuma, Tomoyuki; Komeya, Mitsuru; Ito, Hiroki; Ito, Yusuke; Muraoka, Kentaro; Furuya, Mitsuko; Kato, Ikuma; Fujii, Satoshi; Hamanoue, Haruka; Tamura, Tomohiko; Baba, Masaya; Suda, Toshio; Kodama, Tatsuhiko; Makiyama, Kazuhide; Yao, Masahiro; Shuch, Brian M; Ricketts, Christopher J; Schmidt,Laura; Linehan, W Marston; Nakagawa, Hidewaki; Hasumi, Hisashi
  3. EBioMedicine. 2023, May 12; 92: 104596.
  1. 5.   Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
  2. Li, Yize; Lih, Tung-Shing M; Dhanasekaran, Saravana M; Mannan, Rahul; Chen, Lijun; Cieslik, Marcin; Wu, Yige; Lu, Rita Jiu-Hsien; Clark, David J; Kolodziejczak, Iga; Hong, Runyu; Chen, Siqi; Zhao, Yanyan; Chugh, Seema; Caravan, Wagma; Naser Al Deen, Nataly; Hosseini, Noshad; Newton, Chelsea J; Krug, Karsten; Xu, Yuanwei; Cho, Kyung-Cho; Hu, Yingwei; Zhang, Yuping; Kumar-Sinha, Chandan; Ma, Weiping; Calinawan, Anna; Wyczalkowski, Matthew A; Wendl, Michael C; Wang, Yuefan; Guo, Shenghao; Zhang, Cissy; Le, Anne; Dagar, Aniket; Hopkins, Alex; Cho, Hanbyul; Leprevost, Felipe da Veiga; Jing, Xiaojun; Teo, Guo Ci; Liu, Wenke; Reimers, Melissa A; Pachynski, Russell; Lazar, Alexander J; Chinnaiyan, Arul M; Van Tine, Brian A; Zhang, Bing; Rodland, Karin D; Getz, Gad; Mani, D R; Wang, Pei; Chen, Feng; Hostetter, Galen; Thiagarajan,Mathangi; Linehan, W Marston; Fenyö, David; Jewell, Scott D; Omenn, Gilbert S; Mehra, Rohit; Wiznerowicz, Maciej; Robles, Ana I; Mesri, Mehdi; Hiltke, Tara; An, Eunkyung; Rodriguez, Henry; Chan, Daniel W; Ricketts, Christopher J; Nesvizhskii, Alexey I; Zhang, Hui; Ding, Li
  3. Cancer Cell. 2023, Jan 9; 41(1): 139-163.
  1. 6.   Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugate
  2. Funasaki, Shintaro; Mehanna, Sally; Ma, Wenjuan; Nishizawa, Hidekazu; Kamikubo, Yasuhiko; Sugiyama, Hiroshi; Ikeda, Shuji; Motoshima, Takanobu; Hasumi, Hisashi; Linehan, W Marston; Schmidt,Laura; Ricketts, Chris; Suda, Toshio; Oike, Yuichi; Kamba, Tomomi; Baba, Masaya
  3. Cancer Science. 2022, Apr 09;
  1. 7.   Characterizing the tumor microenvironment in rare renal cancer histological types
  2. Synnott, Naoise C; Poeta, Maria Luana; Costantini, Manuela; Pfeiffer, Ruth M; Li, Mengying; Golubeva,Yelena; Lawrence, Scott; Mutreja,Karun; Amoreo, Carla; Dabrowska, Malgorzata; Simone, Giuseppe; Pescarmona, Edoardo; Lenz,Petra; Olanich, Mary; Duggan, Maire; Abubakar, Mustapha; Fazio, Vito Michele; Gallucci, Michele; Sentinelli, Steno; Landi, Maria Teresa
  3. The Journal of Pathology. Clinical Research. 2021, Oct 07;
  1. 8.   Comprehensive characterization of Alu-mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families
  2. Vocke, Cathy D.; Ricketts, Christopher J.; Schmidt,Laura; Ball, Mark W.; Middelton, Lindsay A.; Zbar, Berton; Linehan, W. Marston
  3. Human Mutation. 2021, Mar 06; 42(5): 520-529.
  1. 9.   Clinical and Molecular Characterization of Microphthalmia-Associated Transcription Factor (MITF)-Related Renal Cell Carcinoma
  2. Lang, Martin; Vocke, Cathy D; Ricketts, Christopher J; Metwalli, Adam R; Ball, Mark W; Schmidt,Laura; Linehan, W Marston
  3. Urology. 2021, Mar; 149: 89-97.
  1. 10.   The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
  2. Ricketts, Christopher J; De Cubas, Aguirre A; Fan, Huihui; Smith, Christof C; Lang, Martin; Reznik, Ed; Bowlby, Reanne; Gibb, Ewan A; Akbani, Rehan; Beroukhim, Rameen; Bottaro, Donald P; Choueiri, Toni K; Gibbs, Richard A; Godwin, Andrew K; Haake, Scott; Hakimi, A Ari; Henske, Elizabeth P; Hsieh, James J; Ho, Thai H; Kanchi, Rupa S; Krishnan, Bhavani; Kwaitkowski, David J; Lui, Wembin; Merino, Maria J; Mills, Gordon B; Myers, Jerome; Nickerson, Michael L; Reuter, Victor E; Schmidt, Laura S; Shelley, C Simon; Shen, Hui; Shuch, Brian; Signoretti, Sabina; Srinivasan, Ramaprasad; Tamboli, Pheroze; Thomas, George; Vincent, Benjamin G; Vocke, Cathy D; Wheeler, David A; Yang, Lixing; Kim, William T; Robertson, A Gordon; Spellman, Paul T; Rathmell, W Kimryn; Linehan, W Marston
  3. Cell Reports. 2018, Apr 03; 23(1): 313-326.e5.
  1. 11.   Anticancer activity of Schiff base-Poloxamer P85 combination against kidney cancer
  2. Dogan, Aysegul; Demirci, Selami; Telci, Dilek; Canikyan, Serli; Kongur, Merve; Dede, Bülent; Sahin, Fikrettin
  3. International urology and nephrology. 2018, Feb; 50(2): 247-255.
  1. 12.   Pax8, Napsin A, and CD10 as Immunohistochemical Markers of Canine Renal Cell Carcinoma
  2. Peat, Tyler J; Edmondson, Elijah; Miller, Margaret A; DuSold, Dee M; Ramos-Vara, José A
  3. Veterinary Pathology. 2017, Jul; 54(4): 588-594.
  1. 13.   Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer
  2. Cherkasova, E.; Malinzak, E.; Rao, S.; Takahashi, Y.; Senchenko, V. N.; Kudryavtseva, A. V.; Nickerson, M. L.; Merino, M.; Hong, J. A.; Schrump, D. S.; Srinivasan, R.; Linehan, W. M.; Tian, X.; Lerman, M. I.; Childs, R. W.
  3. Oncogene. 2011, Nov; 30(47): 4697-4706.
  1. 14.   Identification and characterization of a novel folliculin-interacting protein FNIP2
  2. Hasumi, H.; Baba, M.; Hong, S. B.; Hasumi, Y.; Huang, Y.; Yao, M.; Valera, V. A.; Linehan, W. M.; Schmidt, L. S.
  3. Gene. 2008 415(1-2): 60-67.
  1. 15.   Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer
  2. Wei, M. H.; Toure, O.; Glenn, G. M.; Pithukpakorn, M.; Neckers, L.; Stolle, C.; Choyke, P.; Grubb, R.; Middelton, L.; Turner, M. L.; Walther, M. M.; Merino, M. J.; Zbar, B.; Linehan, W. M.; Toro, J. R.
  3. Journal of Medical Genetics. 2006, JAN; 43(1): 18-27.
  1. 16.   In vivo hydrodynamic delivery of cDNA encoding IL-2: Rapid, sustained redistribution, activation of mouse NK cells, and therapeutic potential in the absence of NKT cells
  2. Ortaldo, J. R.; Winkler-Pickett, R. T.; Bere, E. W.; Watanabe, M.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2005, JUL 15; 175(2): 693-699.
  1. 17.   Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: A clinical and molecular genetic investigation
  2. Matyakhina, L.; Freedman, R. J.; Bourdeau, I.; Wei, M. H.; Stergiopoulos, S. G.; Chidakel, A.; Walther, M.; bu-Asab, M.; Tsokos, M.; Keil, M.; Toro, J.; Linehan, W. M.; Stratakis, C. A.
  3. Journal of Clinical Endocrinology & Metabolism. 2005, JUN; 90(6): 3773-3779.
  1. 18.   Metallothionein-I/II double knockout mice are hypersensitive to lead-induced kidney carcinogenesis: Role of inclusion body formation
  2. Waalkes, M. P.; Liu, J.; Goyer, R. A.; Diwan, B. A.
  3. Cancer Research. 2004, NOV 1; 64(21): 7766-7772.
  1. 19.   Early onset hereditary papillary renal carcinoma: Germline missense mutations in the tyrosine kinase domain of the met proto-oncogene
  2. Schmidt, L. S.; Nickerson, M. L.; Angeloni, D.; Glenn, G. M.; Walther, M. M.; Albert, P. S.; Warren, M. B.; Choyke, P. L.; Torres-Cabala, C. A.; Merino, M. J.; Brunet, J.; Berez, V.; Borras, J.; Sesia, G.; Middelton, L.; Phillips, J. L.; Stolle, C.; Zbar, B.; Pautler, S. E.; Linehan, W. M.
  3. Journal of Urology. 2004, OCT; 172(4): 1256-1261.
  1. 20.   Genetic basis of cancer of the kidney: Disease specific approaches to therapy
  2. Linehan, W. M.; Vasselli, J.; Srinivasan, R.; Walther, M. M.; Merino, M.; Choyke, P.; Vocke, C.; Schmidt, L.; Isaacs, J. S.; Glenn, G.; Toro, J.; Zbar, B.; Bottaro, D.; Neckers, L.
  3. Clinical Cancer Research. 2004, SEP 15; 10(18, Part 2 Suppl. S): 6282S-6289S.
  1. 21.   Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location
  2. Maranchie, J. K.; Afonso, A.; Albert, P. S.; Kalyandrug, S.; Phillips, J. L.; Zhou, S.; Peterson, J.; Ghadimi, B. M.; Hurley, K.; Riss, J.; Vasselli, J. R.; Ried, T.; Zbar, B.; Choyke, P.; Walther, M. M.; Klausner, R. D.; Linehan, W. M.
  3. Human Mutation. 2004 23(1): 40-46.
  1. 22.   Searching for the hereditary causes of renal-cell carcinoma
  2. Pavlovich, C. P.; Schmidt, L. S.
  3. Nature Reviews Cancer. 2004 4(5): 381-393.
  1. 23.   Sensitivity of renal cell carcinoma to aminoflavone: Role of CYP1A1
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Hose, C.; Linehan, W. M.; Worrell, R.; Rubinstein, L.; Sausville, A.; Vistica, D. T.
  3. Journal of Urology. 2004 171(4): 1688-1697.
  1. 24.   Immune effects of escalating doses of granulocyte-macrophage colony-stimulating factor added to a fixed, low-dose, inpatient interleukin-2 regimen: A randomized phase I trial in patients with metastatic melanoma and renal cell carcinoma
  2. Smith, J. W.; Kurt, R. A.; Baher, A. G.; Denman, S.; Justice, L.; Doran, T.; Gilbert, T.; Alvord, W. G.; Urba, W. J.
  3. Journal of Immunotherapy. 2003 26(2): 130-138.
  1. 25.   Critical tumor-suppressor gene regions on chromosome 3p in major human epithelial malignancies: Allelotyping and quantitative real-time PCR
  2. Braga, E.; Senchenko, V.; Bazov, I.; Loginov, W.; Liu, J.; Ermilova, V.; Kazubskaya, T.; Garkavtseva, R.; Mazurenko, N.; Kisseljov, F.; Lerman, M. I.; Klein, G.; Kisselev, L.; Zabarovsky, E. R.
  3. International Journal of Cancer. 2002 100(5): 534-541.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel